sparsentan will minimize the extent or effect of modafinil by impacting hepatic enzyme CYP2C19 metabolism. Use Warning/Monitor. Sparsentan (a CYP2C19 inducer) decreases exposure of CYP2C19 substrates and minimizes efficacy connected to these substrates. itraconazole will raise the stage or impact of modafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use https://modafinil54210.blogolize.com/top-guidelines-of-modafinil-65489218